Adam Parker of Trivariate Research Recommends Eli Lilly’s Dividend as a Defensive Play
According to Adam Parker, founder of Trivariate Research, investors aiming for a defensive approach might want to look at select dividend-paying stocks.
Posts Tagged ‘Eli Lilly and Company (NYSE:LLY)’
10 Best Dividend Stocks to Buy for Dependable Dividend Growth
Dividend stocks continue to be a favored option among investors for their reliable income potential.
Eli Lilly, Juvena Therapeutics Partner to Develop Muscle-Boosting Drugs Using AI Platform
Eli Lilly and Company (NYSE:LLY) is one of the best stocks to buy for beginners now.
Eli Lilly’s Dividend May Be Small, But its Growth Tells a Bigger Story
The company’s underlying business is thriving, with analysts projecting its market value could hit $1 trillion in the coming years.
15 Best Next Generation Dividend Aristocrats to Buy
The next generation of dividend aristocrats can often be spotted through their consistent dividend growth, solid starting yields, and overall stability, even if they haven’t...
10 Best Stocks to Buy For Beginners Now
On June 12, Dan Niles, Niles Investment Management founder and portfolio manager, joined CNBC's 'Squawk Box' to discuss the state of the economy and how he expects the market ...
Goldman Sachs Remains a Buy on Eli Lilly (LLY) With an $883 Price Target
Eli Lilly and Company (NYSE:LLY) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Analyst Asad Haider from Goldman Sachs maintained a Buy rating on Eli Lilly...
Jim Cramer on Eli Lilly: “We Like It”
Eli Lilly and Company (NYSE:LLY) is one of the 17 stocks that Jim Cramer commented on.
11 Best Drug Stocks to Buy According to Hedge Funds
Health and Human Services Secretary Robert F. Kennedy Jr.
15 Best Stocks to Invest in for an 18 Year Old
The Bureau of Labor Statistics stated on June 11 that consumer prices increased less than anticipated in May given that President Donald Trump's tariffs had not yet had a noticeable...
Jim Cramer Commented on These 17 Stocks
On Friday, Mad Money host Jim Cramer shared his evolving view of Elon Musk’s company as he provided both praise and caution in light of recent developments involving Musk and...
Eli Lilly (LLY)’s Target Price Slashed to $960 by TD Cowen, Reiterates Buy Rating
This target price adjustment aligns with investors shifting their focus towards the third quarter results of the SURPASS-CVOT trial.
Camurus, Eli Lilly Collaborate for Long-Acting Incretin Products Using FluidCrystal Technology
On Tuesday, Camurus (OTC:CAMRF) and Eli Lilly and Company (NYSE:LLY) entered into a collaboration and license agreement.
Nxera Hits Important Milestone in Diabetes Drug Partnership with Eli Lilly
In collaboration with Eli Lilly and Company (NYSE:LLY), a pharmaceutical company recognized globally for its innovative diabetes and metabolic therapies, Nxera Pharma has reached...
BMO Maintains Outperform Rating on Eli Lilly (LLY), Sets $900 PT
On May 30, BMO Capital Markets reiterated its Outperform rating on Eli Lilly and Company (NYSE:LLY), setting a price target of $900 following the company’s announcement of a...
Was Jim Cramer Right About Eli Lilly and Company (LLY)?
We recently published a list of Did Jim Cramer Nail or Miss These 11 Stock Predictions? In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) ...
Did Jim Cramer Nail or Miss These 11 Stock Predictions?
During the most recent episode of Mad Money, which aired on Tuesday the 27th of May, Jim Cramer opened with a passionate defense of the artificial intelligence boom, warning viewers...
Jim Cramer Notes Eli Lilly (LLY) Stock is at a “Decent Level to Start a Position”
We recently published a list of Jim Cramer Had These 21 Stocks on His Radar.
Eli Lilly Targets Pain Management Opportunity with SiteOne Therapeutics Acquisition
Eli Lilly and Company (NYSE:LLY) is expanding its footprint into the non-opioid pain management market in pursuit of growth opportunities.
Jim Cramer Had These 21 Stocks on His Radar
Jim Cramer, host of Mad Money, pointed out on Friday that the markets just experienced their worst week since early April and highlighted a mix of pressures affecting investors...
Eli Lilly and Company (LLY) Gains Approval in Australia for Early Alzheimer’s Treatment
Eli Lilly and Company (NYSE:LLY) recently announced that Australia's Therapeutic Goods Administration (TGA) has approved Kisunla (donanemab) for marketing.
12 Best Major Stocks to Buy According to Billionaires
The U.S. stock market had one of the worst starts, at least the worst start to a presidency since 1928.
13 Stocks on Jim Cramer’s Radar Recently
On Monday's episode of Mad Money, Jim Cramer broke down the day’s market rally and argued in favor of staying invested, even in times of uncertainty.
Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
10 Best Income Stocks to Invest in Now
Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive strategy.
Jim Cramer Says AI Is Back & Discusses These 10 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on how market sentiment towards AI appeared to be changing. "Yeah look, this is a moment where, if...
How Did Jim Cramer’s 12 Bold Predictions Play Out?
During the most recent episode of Mad Money, Jim Cramer revisited the recent turbulence in artificial intelligence stocks, three months after the emergence of DeepSeek, a Chinese...
Jim Cramer’s Game Plan for This Week: 16 Stocks in Focus
On Friday, Mad Money host Jim Cramer took a close look at what he called one of the most important stretches of the earnings season, which came alongside major economic developments...
10 Best Long-Term Dividend Stocks to Buy According to Billionaires
Dividend stocks are increasingly popular with both every day and billionaire investors.
Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential
The healthcare industry, an essential component of global well-being and economic resilience, is undergoing significant changes.
10 Best Stocks to Invest in for Long Term
The markets have had two monster years with the S&P 500 index surging 24.73% and 24.01% in 2023 and 2024, respectively.
Jim Cramer Says Trump’s Fed Chair Tussle Is Like “The Godfather” & Discusses These 10 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed whether President Trump could fire the chairman of the Federal Reserve, Jerome Powell.
10 Best Stocks That Will Always Grow
Threats of an impending recession are looming over the stock market due to Trump's tariffs and macroeconomic uncertainty.
13 Best American Dividend Stocks to Buy According to Analysts
Dividend-paying stocks have long benefited investors by delivering consistent and solid returns.
10 Best Low Volatility Stocks to Buy Now
The US stock market experienced a turbulent first quarter of 2025, marked by increased volatility and negative returns across the major indices.
10 Innovative Healthcare Stocks to Watch in 2025
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.
10 Best Long Term Stocks to Buy According to Billionaires
Dividend-paying stocks have traditionally been seen as a solid foundation for investment portfolios, offering steady income and helping cushion the impact of market swings.
15 Best Blue Chip Stocks to Buy According to Billionaires
The US stock market is showing volatility after President Donald Trump's recent announcement of sweeping 10% tariffs on all US trading partners and higher tariffs on countries...
10 Best Pharma Stocks to Buy for Long Term Growth
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before.
10 High Growth Forever Dividend Stocks To Invest In
Dividend stocks have trailed the broader market over the past two years, largely due to investors favoring AI-focused companies.
Jim Cramer Reacts to the Surprise Market Surge and Highlights 8 Key Stocks
In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer analyzed the extraordinary market turnaround following President Trump’s unexpected 90-day tariff reprieve...
10 Best Medical Stocks to Buy According to Billionaires
Some experts view medical, healthcare, and big pharma stocks as immune from trade carnage, making them a safe haven amid the uncertainty brought about by Trump's tariffs.
10 High Growth Dividend Paying Stocks To Invest In
Amid growing concerns about economic growth and President Trump's tariffs, investors have been seeking safer investment options.
10 Defensive Stocks Billionaire Ken Fisher Is Betting On
Ken Fisher, an American billionaire investor, author, and financial analyst, founded and runs Fisher Asset Management.
Jim Cramer Nailed These 11 Stock Picks
On Thursday, April 3rd, the host of Mad Money opened the most recent show by addressing the growing concerns surrounding the current tariff policies.
Starter Stock Portfolio: 12 Safe Stocks to Buy
The US stock market has experienced a turbulent first quarter of 2025, marked by increased volatility and negative returns across the major indices.
Jim Cramer’s Take on These 10 Stocks
On Wednesday, Jim Cramer, the host of Mad Money, shared his concerns about President Donald Trump's approach to trade and its implications for investors.
8 Best Gene-Editing Stocks to Buy
Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases.
10 Best Healthcare Stocks to Buy According to Billionaires
Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech and AI.
Billionaire Ken Fisher’s Top 13 Growth Stock Picks
“Who am I to tell you anything, much less anything that counts? Or that there are only three questions that count and I know what they are? Why should you bother reading any...
